Enzyme Catalysis Biomotor Engineering of Neutrophils for Nanodrug Delivery and Cell-Based Thrombolytic Therapy
Source abstract
Abstract
Utilizing neutrophils (NEs) to target and deliver nanodrugs to inflammation sites has received considerable attention. NEs are involved in the formation and development of thrombosis by transforming into neutrophil extracellular traps (NETs); this indicates that NEs may be a natural thrombolytic drug delivery carrier. However, NEs lack an effective power system to overcome blood flow resistance and enhance targeting efficiency. Herein, we report the application of a urease catalysis micromotor powered NEs nanodrug delivery system to promote thrombolysis and suppress rethrombosis. The urease micromotor powered Janus NEs (UM-NEs) were prepared by immobilizing the enzyme asymmetrically onto the surface of natural NEs and then loading urokinase (UK) coupled silver (Ag) nanoparticles (Ag-UK) to obtain the UM-NEs (Ag-UK) system. Urease catalytic endogenous urea is used to generate thrust by producing ammonia and carbon dioxide, which propels NEs actively targeting the thrombus. The UM-NEs (Ag-UK) can be activated by enriched inflammatory cytokines to release NETs at the thrombosis site, resulting in a concomitant release of Ag-UK. Ag-UK induces thrombolysis to restore vascular recanalization. This urease micromotor-driven NEs drug delivery system can significantly reduce the hemorrhagic side effects, promote thrombolysis, and inhibit rethrombosis with high bioavailability and biosafety, which can be used for the treatment of thrombotic diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, 2999 Jinshan Road, Huli District, Xiamen, China 361006
Funding
Xiamen Medical and Health Guidance Project
References (53)
Show source-provided references
1. 10.1016/B978-1-4377-0792-2.50009-210.1016/B978-1-4377-0792-2.50009-2 ↗
2. 10.1161/ATVBAHA.120.31575410.1161/ATVBAHA.120.315754 ↗
3. 10.2217/14750708.2.5.70910.2217/14750708.2.5.709 ↗
4. 10.1016/j.biomaterials.2009.06.00610.1016/j.biomaterials.2009.06.006 ↗
5. 10.1182/blood-2014-08-55927810.1182/blood-2014-08-559278 ↗
6. 10.1016/j.biomaterials.2020.12029710.1016/j.biomaterials.2020.120297 ↗
7. 10.1111/j.1432-2277.2009.01037.x10.1111/j.1432-2277.2009.01037.x ↗
8. 10.1021/acsnano.0c0993910.1021/acsnano.0c09939 ↗
9. 10.1021/acsnano.8b0927710.1021/acsnano.8b09277 ↗
10. 10.2147/IJN.S25087210.2147/IJN.S250872 ↗
11. 10.1016/S1734-1140(12)70901-510.1016/S1734-1140(12)70901-5 ↗
12. 10.1016/j.jddst.2020.10162810.1016/j.jddst.2020.101628 ↗
13. 10.1007/978-981-33-4497-6_310.1007/978-981-33-4497-6_3 ↗
14. 10.1039/D0CS00461H10.1039/D0CS00461H ↗
15. 10.1002/advs.20180038210.1002/advs.201800382 ↗
16. 10.1016/j.jconrel.2017.03.03510.1016/j.jconrel.2017.03.035 ↗
17. 10.1021/acs.nanolett.7b0233010.1021/acs.nanolett.7b02330 ↗
18. 10.1002/adfm.20170109310.1002/adfm.201701093 ↗
19. 10.7150/thno.1927910.7150/thno.19279 ↗
20. 10.1002/adma.20190182810.1002/adma.201901828 ↗
21. 10.7150/thno.3858310.7150/thno.38583 ↗
22. 10.1038/nbt.418110.1038/nbt.4181 ↗
23. 10.1038/s41467-018-07250-610.1038/s41467-018-07250-6 ↗
24. 10.1038/nnano.2017.5410.1038/nnano.2017.54 ↗
25. 10.1126/scirobotics.aba613710.1126/scirobotics.aba6137 ↗
26. 10.1126/sciadv.aaz901410.1126/sciadv.aaz9014 ↗
27. 10.3389/fphar.2020.0002410.3389/fphar.2020.00024 ↗
28. 10.1073/pnas.202276911810.1073/pnas.2022769118 ↗
29. 10.1161/ATVBAHA.119.31246310.1161/ATVBAHA.119.312463 ↗
30. 10.1016/j.thromres.2018.08.00510.1016/j.thromres.2018.08.005 ↗
31. 10.1038/nri.2017.10510.1038/nri.2017.105 ↗
32. 10.1055/s-0038-167704010.1055/s-0038-1677040 ↗
33. 10.1038/srep2871710.1038/srep28717 ↗
34. Xu H. · arXiv · 2019 · 1904.12684
35. 10.1021/acs.nanolett.1c0029010.1021/acs.nanolett.1c00290 ↗
36. 10.1021/acs.langmuir.9b0331510.1021/acs.langmuir.9b03315 ↗
37. 10.1002/adfm.20170508610.1002/adfm.201705086 ↗
38. 10.1063/5.002906010.1063/5.0029060 ↗
39. 10.1039/C1AN15875A10.1039/C1AN15875A ↗
40. 10.1080/13102818.2015.100819210.1080/13102818.2015.1008192 ↗
41. 10.1021/la301370y10.1021/la301370y ↗
42. 10.1103/PhysRevLett.99.04810210.1103/PhysRevLett.99.048102 ↗
43. 10.1021/jp802622610.1021/jp8026226 ↗
44. 10.1007/BF0332343810.1007/BF03323438 ↗
45. 10.1126/science.109238510.1126/science.1092385 ↗
46. 10.1016/j.cub.2011.03.02110.1016/j.cub.2011.03.021 ↗
47. 10.1016/j.redox.2021.10200310.1016/j.redox.2021.102003 ↗
48. 10.1039/C5IB00225G10.1039/C5IB00225G ↗
49. 10.1155/2012/12186710.1155/2012/121867 ↗
50. 10.1111/j.1538-7836.2011.04544.x10.1111/j.1538-7836.2011.04544.x ↗
51. 10.1038/nnano.2017.5410.1038/nnano.2017.54 ↗
52. 10.1016/j.intimp.2019.10578710.1016/j.intimp.2019.105787 ↗
53. 10.1088/2631-6331/ac25e910.1088/2631-6331/ac25e9 ↗